Pathobio retreat 2017

News & Events

Calendar of Events

Visit our calendar of events to see when our thesis seminars and journal club events are taking place. Prospective students are welcome!

News & Announcements

Here are some of the recent happenings in our program.

Byung Woo Kim

Pathobiology Thesis Seminar

Speaker: Byung Woo Kim (Ph.D. Candidate)
Title: Human Motor Neurons with SOD1 Mutations Generated from Genome-Edited and Patient-Derived iPSCs Manifest Proteinopathy, Axonopathy, and Aberrant Synaptic Function
Place: Zoom Access Link
Advisor: Dr. Lee J. Martin

Awards and Publications

Here are some of our students' accomplishments.

Lionel Chia

Congratulations to Lionel Chia!

For his work presented on how HMGA1 induces FGF19 to foster tumor-stromal cell crosstalk and drive tumor progression in pancreatic ductal adenocarcinoma, Lionel Chia received the AACR-Doreen J. Putrah Cancer Research Foundation Scholar-in-Training Award. Lionel presented at the 2020 AACR Annual Meeting, which took place virtually due to the COVID-19 pandemic. Scholar-in-Training Awards are competitive and are presented to those with high-quality abstracts and applications from a large candidate pool.

Lionel is a 4th year PhD student in the Graduate Program in Pathobiology under the mentorship of Dr. Linda Resar, whose laboratory focuses on studying molecular mechanisms leading to cancer, blood diseases, sickle cell anemia, hemophilia and other coagulopathies. Lionel is studying the role of the chromosomal architectural protein HMGA1 in prostate and pancreatic cancer. He hopes that by understanding more about HMGA1, he would be able to develop additional therapies against HMGA1 and its associated pathways to treat cancer. Outside of the laboratory, Lionel’s interests include playing his guitar, running, and spending time with friends.

Youngran Park

Congratulations to Dr. Youngran Park!

We are proud to announce that Dr. Youngran Park, a 2017 graduate of the Pathobiology PhD Graduate Program, along with collaborators, has recently had a 1st author paper published in the journal, Clinical Cancer Research entitled: Loss of ARID1A in tumor cells renders selective vulnerability ionizing radiation and PARP inhibitor therapy.